Gene Query: EPOR

Dataset Description Geneva Score
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 36.93
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 36.68
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 33.09
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 32.66
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 31.69
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 24.23
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 24.23
Epigenomic landscape during organ formation in human early embryos 23.74
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 23.41
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 23.14
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 22.9
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 20.02
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 16.44
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 16.44
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 15.09
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.47
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 12.32
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 12.06
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 12.02
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 11.74
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 11.02
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 11.02
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 10.86
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 10.85
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 10.8
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 10.61
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 10.58
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 10.25
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 9.79
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 9.59
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 9.59
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 9.14
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 8.6
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 8.52
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 8.45
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 8.21
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 7.62
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 7.16
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 7.11
MEIS1 regulates hematopoiesis in hPSCs 6.8
Tyrosine Kinase Inhibitor Cardiotoxicity 6.69
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 6.69
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 6.68
Developmental stage specific chromosome architecture in human erythroid cells 6.68
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 6.56
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 6.56
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 6.37
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.05
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 6.05
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.97
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 5.72
RNA-seq of tumor cells following angiopellosis extravasation 5.47
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 5.43
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.36
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 5.23
U2AF1 mutations alter splice site recognition in hematological malignancies 5.17
Transcriptional responses of human insulinoma cells to acute cytokine exposure 5.01
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.92
Statins modulate endothelial transcriptional profile by inhibiting EZH2 4.83
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.8
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.8
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 4.54
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.51
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 4.44
Discovering human diabetes-risk gene function with genetics and physiological assays 4.11
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 4.09
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 3.99
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 3.99
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.9
Transciptomic profiling of human fetal lung samples 3.85
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 3.85
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.73
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.73
Gene expression changes after LOC550643 silencing 3.72
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 3.72
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.7
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.6
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 3.58
Postnatal lipids drive hepatocyte maturation 3.51
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.44
FOXP2's impact on the primate transcriptome 3.38
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.31
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 3.27
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.19
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.15
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.12
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 3.1
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 3.08
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.04
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 3.02
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.97
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.96
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.96
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 2.92
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 2.92
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.88
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.87
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.81
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.81
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 2.73
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 2.72
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.7
Genome wide expression change by RNF168 knocking down in MCF-7 cells 2.63
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.63
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.56
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.53
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.48
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.47
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 2.45
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.38
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.36
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.34
Identification of long noncoding RNAs in T-ALL cell lines 2.34
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.32
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.32
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.29
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.29
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 2.28
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 2.28
Endometrial transcriptome and PGR cistrome in cycling fertile women 2.28
Transcriptome analysis of human lung epithelial cells 2.28
The human blood-nerve barrier transcriptome 2.25
Tpl-2 small molecule project 2.25
Tpl-2 and MEK small molecule inhibitors 2.25
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 2.23
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.19
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 2.17
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 2.17
Specific molecular signatures underlie response to decitabine in CMML 2.17
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 2.15
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 2.14
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.12
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.12
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.11
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 2.11
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.08
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.08
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 2.01
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.0
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 1.99
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.98
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.97
Stem and effector CD8 T-cells from human cancers 1.96
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 1.92
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.88
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.88
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.88
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 1.87
Clinker: visualizing fusion genes detected in RNA-seq data 1.85
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.83
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 1.82
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.81
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.81
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.81
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 1.81
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 1.8
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 1.79
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.79
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.79
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.78
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.77
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.77
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.77
Bone marrow derived human B cells [normal proB] 1.77
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.75
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 1.73
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 1.73
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.72
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 1.71
Paxillin regulates genomic networks in prostate cancer [LNCaP] 1.69
Mechanistic Model-Guided Study of Embryonic Morphogenesis 1.69
Short and Long RNA sequencing of human mature erythrocytes 1.68
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.68
Control of prostate tumour growth by the long non-coding RNA GHSROS 1.66
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.66
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.66
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.65
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.65
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.64
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.62
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 1.59
Accurate annotation of human protein-coding small open reading frames 1.59
AUF-1 affected genes in human skin cells 1.57
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 1.56
Reprogrammed myeloid cell transcriptomes in NSCLC 1.55
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.54
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.53
RNA-seq in transgenic cells 1.53
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.52
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 1.51
RNA-seq analysis of uveal melanoma cells treated with FR900359 1.51
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.49
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.49
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 1.48
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.45
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.44
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.42
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.42
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.42
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 1.42
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 1.41
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.38
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.36
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 1.36
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 1.36
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.36
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.35
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.35
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.34
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 1.34
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.33
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.33
Repurposing of promoters and enhancers during mammalian evolution 1.33
Transcriptome analysis of U87 cells upon LINC00152 knockdown 1.32
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.32
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.32
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 1.32
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 1.32
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 1.31
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.31
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 1.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 1.3
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.29
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.29
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.28
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.28
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.27
NR2F2 study 1.27
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 1.27
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.26
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 1.25
Investigate A2M treatment on human prostate cancer xenograft in mice 1.24
Investigate A2M treatment on human prostate cancer and mouse liver 1.24
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.23
Gene expression changes due to PARP knockdown in human cells 1.22
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 1.21
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.21
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 1.21
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.21
Patient-derived luminal breast cancer xenografts with progestins 1.21
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 1.2
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 1.19
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 1.19
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 1.16
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 1.16
RNA-seq of SCLC PDX models treated with EP 1.14
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.14
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 1.14
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.14
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 1.14
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 1.14
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.14
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.14
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.12
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 1.12
LNCaP treated with iBET 1.12
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.11
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.11
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.11
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 1.11
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.11
RNA-Seq and expression data from human adipose tissue 1.1
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.1
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.1
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.09
The transcriptome effect of overexpressing EZH2 in MCF7 1.08
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.08
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.08
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.08
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.07
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.07
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.07
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 1.07
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.07
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.06
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.06
RNA-seq analysis of the human fetal kidney. 1.05
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 1.05
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.05
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 1.05
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.04
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.04
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 1.04
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 1.03
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 1.03
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.03
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.03
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.02
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.01
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.99
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.99
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.99
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.99
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.98
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.98
Transcriptome analysis of BAP1 knockout and restoration 0.98
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.98
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.98
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 0.97
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 0.97
Gene expression signatures of innate lymphoid cells from human blood 0.96
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 0.95
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.95
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 0.94
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 0.94
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 0.94
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 0.94
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.94
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 0.94
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 0.92
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.92
High-Throughput Kinetic Analysis of Fractional Killing 0.91
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.91
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.9
STX4 Over-Expression in Human islets 0.9
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.9
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 0.9
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.89
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.89
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.88
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 0.88
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.88
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.88
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 0.88
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.88
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.88
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.87
Leucegene: ALL sequencing 0.86
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.85
ARID1A and ARID1B loss in HCT116 and TOV21G cells 0.84
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.83
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.83
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.83
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 0.83
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 0.82
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.81
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.81
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.81
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.81
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.8
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.8
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 0.8
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.79
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.79
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 0.78
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.77
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.76
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.76
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 0.74
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.74
mRNA recovered upon RNF219 IP. [RNA-IP] 0.73
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.71
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.7
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.7
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.7
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.69
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.69
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.69
RNA-seq analysis of BAP1-depleted uveal melanoma cells 0.68
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.68
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.68
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.67
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.67
RNA editing in nascent RNA affects pre-mRNA splicing 0.66
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.66
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.66
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.66
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.66
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.65
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.65
Single-Cell Genotyping of Transcriptomes 0.65
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.65
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.64
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 0.63
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.63
RNA Seq of HMVEC under hypoxia 0.62
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 0.62
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.61
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.6
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.6
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.6
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 0.6
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.6
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.59
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.58
Transcriptional effect of ETV1 knockdown in melanoma cells 0.57
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.57
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.57
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.56
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.56
Gene expression profile difference among renal location in a stone former 0.55
Expression patterns in chronic thromboembolic pulmonary hypertension 0.55
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.55
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.54
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.54
LIN28A Over-expression RNAseq 0.54
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.53
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.53
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.53
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.52
Differentially expressed vascular development genes for iPSC-ECs from CDI 0.52
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.5
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.5
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.49
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.49
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 0.49
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.49
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.47
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.47
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.47
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.45
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.45
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.44
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.43
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.43
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.42
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.41
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.4
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.39
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.37
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.37
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.36
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.35
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.34
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.34
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.33
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.33
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.33
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.32
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.31
Engineering Patient-Specific Tissue Implants 0.31
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.3
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.29
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.29
RNAseq analysis of ruxolitinib treated breast cancers 0.28
Multiple sclerosis and EAE 0.28
Human optic chiasm from healthy controls and multiple sclerosis patients 0.28
RNA-seq in endometrial stromal tumors 0.28
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.28
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.27
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.26
Gene expression analysis of human hepatocellular cancers 0.26
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 0.26
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.26
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.26
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.26
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.24
DRB/GRO-Seq -/+ UV 0.24
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.22
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.22
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.22
Impact on erythroid progenitor type on erythroid differntiation 0.22
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.21
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.2
miRNAs affected by antagomiR-17 treatment 0.19
ML29755 RNA-seq data 0.19
Transcriptome Profiling of Human Primary Monocytes 0.18
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.18
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.17
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 0.15
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.15
Paxillin regulates genomic networks in prostate cancer [PC3] 0.14
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.14
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.14
Genome-wide identification of cancer-specific alternative splicing in circRNA 0.14
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.14
Epigenomic conservation of transposable element silencing 0.14
Epigenomic conservation of transposable element silencing [RNA-seq] 0.14
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.13
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.13
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.13
Identification of a LIF-responsive replication-competent human β cell 0.12
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.12
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.11
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 0.1
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.1
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.1
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.09
RNA Sequencing of Human iPS derived Cardiomyocytes 0.09
RNA sequencing of human pancreatic cancer cell lines 0.08
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.07
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.06
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.06
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.06
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.06
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.05
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.05
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.04
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.04
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.04
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.04
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.03
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.03
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.02
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.02
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.02
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 0.01
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.01
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation